Delivery Order SPE2DB22D1106-SPE2DB25FEPE6

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,687.64 with a firm fixed price and an ultimate completion date of November 20, 2024. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.73, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a $18,547.86 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VISIPAQUE 320 MG/ML medical bottles, with a period of performance through May 8, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order valued at $4,440.40 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML medical products, with a performance period through May 22, 2025. The contract is placed by the Defense Logistics Agency (DLA), which serves as a critical supplier of pharmaceutical and medical products to various government agencies, including the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.73 firm-fixed-price delivery order is for the supply of Visipaque 320 mg/ml bottles (100 ml) and has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,169.19 firm fixed-price delivery order is for the pharmaceutical product VISIPAQUE 320 MG/ML INFUS BTL 150ML, with a completion date of September 11, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,687.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,236.68 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024 and was awarded on July 17, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The $1,748.62 award is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,118.34 firm-fixed-price delivery order is for the supply of VISIPAQUE 320 mg/ml bottles of 100 ml. The award is not associated with a set-aside program. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, through its Corporate Office division, is a significant supplier of prescription medications, over-the-counter...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEPE6
    Delivery Order

This federal contract award, valued at $1,128.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product, with a performance period ending on May 21, 2025. This delivery order contract is a firm fixed-price type and is not set aside for any specific business category.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables Amerisourcebergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/24/25, 12:49 AM